PEMT rs7946 Polymorphism and Sex Modify the Effect of Adequate Dietary Choline Intake on the Risk of Hepatic Steatosis in Older Patients with Metabolic Disorders
Open Access
Abstract
In humans, PEMT rs7946 polymorphism exerts sex-specific effects on choline requirement and hepatic steatosis (HS) risk. Few studies have explored the interaction effect of the PEMT rs7946 polymorphism and sex on the effect of adequate choline intake on HS risk. In this cross-sectional study, we investigated the association between PEMT polymorphism and adequate choline intake on HS risk. We enrolled 250 older patients with metabolic disorders with (n = 152) or without (n = 98; control) ultrasonically diagnosed HS. An elevated PEMT rs7946 A allele level was associated with a lower HS risk and body mass index in both men and women. Dietary choline intake—assessed using a semiquantitative food frequency questionnaire—was associated with reduced obesity in men only (p for trend < 0.05). ROC curve analysis revealed that the cutoff value of energy-adjusted choline intake for HS diagnosis was 448 mg/day in women (AUC: 0.62; 95% CI: 0.57–0.77) and 424 mg/day in men (AUC: 0.63, 95% CI: 0.57–0.76). In women, GG genotype and high choline intake (>448 mg/day) were associated with a 79% reduction in HS risk (adjusted OR: 0.21; 95% CI: 0.05–0.82); notably, GA or AA genotype was associated with a reduced HS risk regardless of choline intake (p < 0.05). In men, GG genotype and high choline intake (>424 mg/day) were associated with a 3.7-fold increase in HS risk (OR: 3.7; 95% CI: 1.19–11.9). Further adjustments for a high-density lipoprotein level and body mass index mitigated the effect of choline intake on HS risk. Current dietary choline intake may be inadequate for minimizing HS risk in postmenopausal Taiwanese women carrying the PEMT rs7946 GG genotype. Older men consuming more than the recommended amount of choline may have an increased risk of nonalcoholic fatty liver disease; this risk is mediated by a high-density lipoprotein level and obesity.Keywords
Funding Information
- Ministry of Health and Welfare, Taiwan, R.O.C. (202003, 10902, MOST:109-2320-B-030-012-MY3)
- Ministry of Science and Technology, Taiwan, R.O.C. (202003, 10902, MOST:109-2320-B-030-012-MY3)
This publication has 66 references indexed in Scilit:
- Choline intake in a large cohort of patients with nonalcoholic fatty liver diseaseThe American Journal of Clinical Nutrition, 2012
- Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progressionCurrent Opinion in Gastroenterology, 2012
- Impaired de Novo Choline Synthesis Explains Why Phosphatidylethanolamine N-Methyltransferase-deficient Mice Are Protected from Diet-induced ObesityJournal of Biological Chemistry, 2010
- Dose‐response analyses using restricted cubic spline functions in public health researchStatistics in Medicine, 2010
- Genetic Variants in Phosphatidylethanolamine N-methyltransferase and Methylenetetrahydrofolate Dehydrogenase Influence Biomarkers of Choline Metabolism When Folate Intake Is RestrictedJournal of the American Dietetic Association, 2009
- Thematic Review Series: Glycerolipids. Phosphatidylcholine and choline homeostasisJournal of Lipid Research, 2008
- The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese populationJournal of Hepatology, 2007
- Phosphatidylethanolamine N ‐methyltransferase (PEMT) gene expression is induced by estrogen in human and mouse primary hepatocytesThe FASEB Journal, 2007
- Choline: Critical Role During Fetal Development and Dietary Requirements in AdultsAnnual Review of Nutrition, 2006
- Common genetic polymorphisms affect the human requirement for the nutrient cholineThe FASEB Journal, 2006